Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome)

<table class="fixed-width table-group" id="tab5"><tr><td><table class="table"><colgroup><col style="width:5.05em"/><col style="width:12.63em"/><col style="width:6.35em"/><col style="width:7.44em"/><col style="width:4.18em"/></colgroup><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Endpoint</td><td class="align_center"> </td><td class="align_center">SFI (n=70)</td><td class="align_center">Placebo (n=69)</td><td class="align_center">P value</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">6MWD</td><td class="align_center">Posttreatment–pretreatment</td><td class="align_center">113.00±117.55</td><td class="align_center">82.99±127.99</td><td class="align_center">0.0281</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of change in 6MWD (pre-to-post treatment) between SFI and placebo groups.</div>

Evidence-Based Complementary and Alternative Medicine

tab5

Table 5

Table 5: Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome) 

Table 5 | Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome) 